Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Refractory Cough”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Early research (Phase 1)Study completedNCT03773068
What this trial is testing

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

Who this might be right for
Biological Availability
Bayer 30
Not applicableLooking for participantsNCT07488598
What this trial is testing

Efficacy of Behavioral Therapy for Chronic Refractory Cough

Who this might be right for
Chronic Cough
Assiut University 30
Not applicableUnknownNCT05570981
What this trial is testing

A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function

Who this might be right for
Chronic Refractory Cough
Bispebjerg Hospital 30
Not applicableLooking for participantsNCT07070895
What this trial is testing

Cough Management Wellness App for Refractory or Unexplained Chronic Cough

Who this might be right for
Refractory Chronic CoughUnexplained Chronic CoughCough Hypersensitivity
Hyfe Inc 20
Testing effectiveness (Phase 2)Looking for participantsNCT07671924
What this trial is testing

The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)

Who this might be right for
Refractory Chronic Cough
Trevi Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT05392192
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough

Who this might be right for
Chronic Cough
Aldeyra Therapeutics, Inc. 51
Large-scale testing (Phase 3)Study completedNCT03696108
What this trial is testing

Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)

Who this might be right for
Chronic Cough
Merck Sharp & Dohme LLC 175
Testing effectiveness (Phase 2)Study completedNCT04678206
What this trial is testing

Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Who this might be right for
Refractory Chronic Cough
Bellus Health Inc. - a GSK company 310
Large-scale testing (Phase 3)Study completedNCT05599191
What this trial is testing

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Who this might be right for
CoughRefractory Chronic Cough
Bellus Health Inc. - a GSK company 957
Testing effectiveness (Phase 2)Study completedNCT01703923
What this trial is testing

An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough

Who this might be right for
Chronic Refractory Cough
Avalo Therapeutics, Inc. 83
Testing effectiveness (Phase 2)Study completedNCT05660850
What this trial is testing

Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Who this might be right for
Chronic Refractory Cough (CRC) With Non-atopic AsthmaCRC With Atopic AsthmaUnexplained Chronic Cough+2 more
Genentech, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT02612623
What this trial is testing

An 8-Week Refractory Chronic Cough Study (MK-7264-021)

Who this might be right for
Refractory Chronic Cough
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Testing effectiveness (Phase 2)Study completedNCT04562155
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough

Who this might be right for
Refractory and/or Unexplained Chronic Cough
Bayer 310
Testing effectiveness (Phase 2)Study completedNCT05733533
What this trial is testing

Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough

Who this might be right for
Refractory Chronic Cough
Guangdong Hengrui Pharmaceutical Co., Ltd 97
Testing effectiveness (Phase 2)Looking for participantsNCT06960759
What this trial is testing

Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough

Who this might be right for
Chronic Cough (CC)Refractory Chronic CoughUnexplained Chronic Cough
University of Montana 135
Early research (Phase 1)Study completedNCT05628740
What this trial is testing

Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175

Who this might be right for
Refractory Chronic Cough
Nocion Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT03622216
What this trial is testing

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

Who this might be right for
Chronic Cough
Attenua, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT03482713
What this trial is testing

Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)

Who this might be right for
Chronic Cough
Merck Sharp & Dohme LLC 23
Post-approval studies (Phase 4)Not Yet RecruitingNCT07288528
What this trial is testing

A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough

Who this might be right for
CoughRefractory Chronic CoughUnexplained Chronic Cough+2 more
McMaster University 124
Testing effectiveness (Phase 2)Study completedNCT03282591
What this trial is testing

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

Who this might be right for
Refractory Chronic Cough
Vyne Therapeutics Inc. 185
Next Page